Mitsubishi UFJ Trust & Banking’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Sell
7,091
-16,905
-70% -$3.7M ﹤0.01% 734
2026
Q1
$4.54M Sell
23,996
-17,170
-42% -$3M 0.01% 663
2025
Q4
$7M Sell
41,166
-9,703
-19% -$1.49M 0.02% 594
2025
Q3
$6.7M Buy
50,869
+31,016
+156% +$3.72M 0.01% 631
2025
Q2
$2.11M Sell
19,853
-20,521
-51% -$2.23M ﹤0.01% 789
2025
Q1
$5.01M Sell
40,374
-6,951
-15% -$907K 0.01% 677
2024
Q4
$5.83M Buy
47,325
+7,963
+20% +$939K 0.01% 675
2024
Q3
$4.39M Buy
39,362
+31,292
+388% +$3.43M 0.01% 731
2024
Q2
$861K Sell
8,070
-65,687
-89% -$7.22M ﹤0.01% 886
2024
Q1
$8.82M Buy
73,757
+41,950
+132% +$5.14M 0.02% 583
2023
Q4
$3.91M Sell
31,807
-4,712
-13% -$588K 0.01% 714
2023
Q3
$4.73M Sell
36,519
-1,232
-3% -$164K 0.01% 693
2023
Q2
$4.68M Buy
37,751
+428
+1% +$57.6K 0.01% 695
2023
Q1
$5.46M Buy
37,323
+1,517
+4% +$224K 0.01% 667
2022
Q4
$5.7M Buy
35,806
+1,595
+5% +$234K 0.01% 654
2022
Q3
$4.56M Buy
34,211
+912
+3% +$139K 0.01% 675
2022
Q2
$5.2M Sell
33,299
-4,232
-11% -$651K 0.01% 670
2022
Q1
$5.84M Sell
37,531
-30,647
-45% -$4.45M 0.01% 675
2021
Q4
$8.69M Sell
68,178
-13,850
-17% -$1.82M 0.02% 629
2021
Q3
$10.7M Buy
82,028
+3,848
+5% +$581K 0.02% 590
2021
Q2
$14.1M Buy
78,180
+16,921
+28% +$2.93M 0.03% 521
2021
Q1
$10.1M Sell
61,259
-4,509
-7% -$742K 0.02% 591
2020
Q4
$10.9M Buy
65,768
+2,206
+3% +$329K 0.02% 607
2020
Q3
$9.06M Buy
63,562
+3,607
+6% +$447K 0.02% 593
2020
Q2
$6.62M Buy
59,955
+9,026
+18% +$998K 0.02% 649
2020
Q1
$5.08M Sell
50,929
-1,689
-3% -$218K 0.01% 649
2019
Q4
$7.86M Buy
52,618
+3,670
+7% +$499K 0.02% 652
2019
Q3
$6.23M Sell
48,948
-4,714
-9% -$632K 0.02% 676
2019
Q2
$7.41M Buy
53,662
+3,733
+7% +$502K 0.03% 589
2019
Q1
$7M Buy
49,929
+4,931
+11% +$643K 0.03% 579
2018
Q4
$5.58M Sell
44,998
-141
-0.3% -$20.9K 0.02% 602
2018
Q3
$7.59M Sell
45,139
-75,936
-63% -$13.1M 0.03% 579
2018
Q2
$20.9M Buy
121,075
+914
+0.8% +$149K 0.04% 527
2018
Q1
$18.1M Sell
120,161
-147
-0.1% -$21.6K 0.03% 558
2017
Q4
$16.2M Buy
120,308
+598
+0.5% +$82.9K 0.03% 593
2017
Q3
$17.5M Sell
119,710
-1,083
-0.9% -$164K 0.03% 552
2017
Q2
$18.8M Sell
120,793
-584
-0.5% -$89.3K 0.04% 524
2017
Q1
$17.6M Sell
121,377
-69
-0.1% -$8.99K 0.04% 533
2016
Q4
$13.2M Sell
121,446
-3,085
-2% -$344K 0.03% 603
2016
Q3
$15.1M Buy
124,531
+609
+0.5% +$82.1K 0.03% 560
2016
Q2
$17.5M Buy
123,922
+4,248
+4% +$626K 0.04% 496
2016
Q1
$15.6M Buy
119,674
+1,350
+1% +$168K 0.04% 533
2015
Q4
$16.6M Sell
118,324
-353
-0.3% -$48.9K 0.04% 498
2015
Q3
$15.8M Buy
118,677
+4,286
+4% +$738K 0.04% 497
2015
Q2
$20.1M Buy
114,391
+844
+0.7% +$152K 0.05% 448
2015
Q1
$19.6M Buy
113,547
+3,809
+3% +$654K 0.05% 460
2014
Q4
$18M Buy
+109,738
New +$18.2M 0.04% 472

Other funds holding JAZZ

Mitsubishi UFJ Trust & Banking's JAZZ Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking reduced its Jazz Pharmaceuticals (JAZZ) stake by 70% in Q2 2026, selling an estimated $3.7M and leaving 7,091 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Mitsubishi UFJ Trust & Banking first reported a position in JAZZ in Q4 2014 and has held it in 47 quarters since. The position peaked at $20.9M in Q2 2018. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 7,091 shares of Jazz Pharmaceuticals worth $1.71M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking sold 16,905 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.7M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #734 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
  • Mitsubishi UFJ Trust & Banking's Jazz Pharmaceuticals position peaked at $20.9M in Q2 2018.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.